EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Haemostatics (polyvalent protease inhibitors).
Generic
Injection.
Injection, aprotinin 10,000 KIU/ mL.
Aprotonin is a haemostatic. High doses offer major reductions in perioperative blood loss and the need for donor blood transfusions. It is indicated for the treatment of: patients with life threatening haemorrhage due to hyperplasminaemia; patients considered to be at high risk of major blood loss associated with open heart surgery with extracorporeal circulation; patients in whom blood transfusion is not an option so that optimal blood conservation during open heart surgery is an absolute priority (eg, Jehovah's witnesses).
To be given by slow intravenous injection or infusion. Hyperplasminaemia: 500,000 to 1, 000,000 KIU (277.8 - 555.6 Ph. Eur. units) (maximum rate 10mL/ minute) followed by 200,000 KIU minute) followed by 200,000 KIU (111.1 Ph. Eur. units) hourly if necessary, until bleeding stops.
Hyperplasminaemia: It is recommended that a dose proportional to the adult dose, based on body weight, is calculated. Open heart surgery: Dosage has not been established.
Hyperplasminaemia: The dosage above relates to persons of average body weight. Reductions of these doses should be considered in patients of below average weight. Open heart surgery: Refer to Summary of Product Characteristics.
Known hypersensitivity to aprotinin.
Avoid rapid intravenous injection of large doses. Caution in patients treated intermittently or patients treated previously with aprotinin; discontinue treatment if hypersensitivity reactions are observed. Adding aprotinin to heparinised blood prolongs activated clotting time. Pregnancy and lactation.
None stated.
Local thrombophlebitis, nausea and vomiting, diarrhoea, muscle pains, blood pressure changes. Allergic reactions such as erythema, urticaria and bronchospasm have occurred occasionally. Also, anaphylaxis, tachycardia, pallor or cyanosis, dyspnoea. Reddening of skin on repeated dosage.
Ferring
(POM)
04 June 2009




